Noninvasive imaging in congenital heart disease

Current Opinion in Cardiology

Volumn 15, Issue 4, 2000, Pages 224-237

  Russell, Jennifer ^a   Justino, Henri ^a   Dipchand, Anne ^a   Yoo, Shi Joon ^b   Kim, Yang Min ^c   Freedom, Robert M ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c Sejong Heart Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; GADOLINIUM;

ALGORITHM; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL HEART DISEASE; CONTRAST ECHOCARDIOGRAPHY; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART MUSCLE PERFUSION; HUMAN; IMAGING; INTRAOPERATIVE PERIOD; INTRAVASCULAR ULTRASOUND; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REOPERATION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; TISSUE CHARACTERIZATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 0033930727     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200007000-00004     Document Type: Review

References (84)

1. 1 Fellows KE, Hubbard AM: MRI; complacency or ascendency in the evaluation of congenital heart disease. Pediatr Radiol 1999, 29:491-495.
2. 2 Smith H-J: Cardiac MR imaging. Acta Radiologica 1999, 40:1-22. This review article provides a comprehensive but well balanced overview of cardiac MR.
3. 3 Didier D, Ratib O, Beghetti M, et al.: Morphologic and functional evaluation of congenital heart disease by magnetic resonance imaging. J Magn Reson Imaging 1999, 10:639-655.
4. 4 de Roos A, Roest AAW: Evaluation of congenital heart disease by magnetic resonance imaging. Eur Radiol 2000, 10:2-6.
5. 5 Applegate KE, Goske MJ, Pierce G, et al.: Situs revisited: imaging of the heterotaxy syndrome. Radiographies 1999, 19:837-852.
6. 6 Forster J, Sieverding L, Breuer J, et al.: High-resolution cardiac imaging using an interleaved 3D double slab technique. Magn Reson Imaging 1998, 16:1155-1162.
7. 7 Roche KJ, Krinsky G, Lee VS, et al.: Interrupted aortic arch: diagnosis with gadolinium-enhanced 3D MRA. J Comput Assist Tomogr 1999, 23:197-202.
8. 8 Neimatallah MA, Ho VB, Dong Q, et al.: Gadolinium-enhanced 3D magnetic resonance angiography of the thoracic vessels. J Magn Reson Imaging 1999, 10:758-770. This review article on MR angiography compiles most of the scattered information regarding the techniques, pifalls, and application of this relatively new imaging modality.
9. 9 Bekedam MA, Vliegen HW, Doornbos J, et al.: Diagnosis and management of anomalous origin of the right coronary artery from the left coronary sinus. Int J Card Imaging 1999, 15:253-258. This article emphasizes the role of MR coronary imaging in the diagnosis of anomalous coronary arteries.
10. 10 Taylor CA, Thorne SA, Rubens MB, et al.: Coronary artery imaging in grown up congenital heart disease: complementary role of magnetic resonance and x-ray coronary angiography. Circulation 2000, 101:1670-1678. This original article analyzed the largest series of MR coronary imaging for congenital heart disease. However, only a few of the patients are children with the lowest age of 11 years.
11. 11 Flacke S, Setser RM, Barger P, et al.: Coronary aneurysms in Kawasaki's disease detected by magnetic resonance coronary angiography. Circulation 2000, 101 :e156-e157.
12. 12 Botnar RM, Stuber M, Damas PG, et al.: Improved coronary arery definition with T2-weighted free-breathing, three-dimensional coronary MRA. Circulation 1999, 99:3139-3148. This article describes an MR technique that can be performed with free breathing.
13. 13 Stuber M, Botnar RM, Danias PG, et al.: Contrast agent-enhanced, free-breathing, three-dimensional coronary magnetic resonance angiography. J Magn Reson Imaging 1999, 10:790-799. This article describes an MR technique that can be performed with free breathing.
14. 14 Fogel MA: Assessment of cardiac function by magnetic resonance imaging. Pediatr Cardiol 2000, 21:59-69. This is a very nice, up-to-date review article on cardiac functional analysis by using MR.
15. 15 Singh GK, Greenberg SB, Yap YS, et al.: Right ventricular function and exercise performance late after primary repair of tetralogy of Fallot with the transannular patch in infancy. Am J Cardiol 1998, 81:1378-1382.
16. 16 Geva T, Powel AJ, Crawford EC, et al.: Evaluation of regional differences in right ventricular systolic function by acoustic quantification echocardiography and cine magnetic resonance imaging. Circulation 1998, 98:339-45.
17. 17 Niezen RA, Helbing WA, van der Wall EE, et al.: Left ventricular function in adults with mild pulmonary insufficiency late after Fallot repair. Heart 1999, 82:697-703. This is a nice study of functional evaluation of the ventricles after total repair of tetralogy of Fallot by using various MR methodologies.
18. 18 Fogel MA, Weinberg PM, Gupta KB, et al.: Mechanics of the single left ventricle: a study in ventricular-ventricular interaction II. Circulation 1998, 98:330-338.
19. 19 Donofrio MT, Clark BJ, Ramaciotti C, et al.: Regional wall motion and strain of transplanted hearts in pediatric patients using magnetic resonance tagging. Am J Physiol 1999, 277(Pt 2):1481-1487. This original article describes the use of MR for analysis of ventricular wall motion after transplantation in children and provides data for basic understanding of posttransplantation ventricular mechanics.
20. 20 Midiri M, Finazzo M, Brancato M, et al.: Arrhythmogenic right ventricular dysplasia: MR features. Eur Radiol 1997, 7:307-312.
21. 21 White RD, Trohman RG, Flamm SD, et al.: Right ventricular arrhythmia in the absence of arrhythmogenic dysplasia: MR imaging of myocardial abnormalities. Radiology 1998, 207:743-751.
22. 22 Wilke NM, Jerosch-Herold M, Zenovich A, et al.: Magnetic resonance first-pass myocardial perfusion imaging: clinical validation and future applications. J Magn Reson Imaging 1999, 10:676-685. This review article has an overview of the present and future of MR in evaluation of myocardial perfusion.
23. 23 Neubauer S: Myocardial metabolism. In Magnetic Resonance of the Heart and Great Vessels. Edited by Bogaert J, Duerinckx AJ, Rademakers FE. Berlin, Germany; 1999:153-168.
24. 24 Powell AJ, Geva T: Blood flow measurement by magnetic resonance imaging in congenital heart disease. Pediatr Cardiol 2000, 21:47-58. This review article has an overview of flow analysis by using phase-contrast imaging in children.
25. 25 Be'eri E, Maier SE, Landzberg MJ, et al.: In vivo evaluation of Fontan pathway flow dynamics by multidimensional phase-velocity magnetic resonance imaging. Circulation 1998, 98:2873-2882.
26. 26 Houlind K, Stenbog EV, Sorensen KE, et al.: Pulmonary and caval flow dynamics after total cavopulmonary connection. Heart 1999, 81:67-72.
27. 27 Fogel MA, Weinber PM, Hoydu A, et al.: The nature of flow in the systemic venous pathway measured by magnetic resonance blood tagging in patients having the Fontan operation. J Thorac Cardiovasc Surg 1997, 114:1032-1041.
28. 28 Fogel MA, Weinberg PM, Rychik J, et al.: Caval contribution to flow in the branch pulmonary arteries of Fontan patients with a novel application of magnetic resonance presaturation pulse. Circulation 1999, 99:1215-1221. This comprehensive article shows the contribution of superior and inferior caval flow to the right and left pulmonary arteries after Fontan operation by using special bood tagging technique.
29. 29 Hayman LA, Ford JJ, Taber KH, et al.: T2 effect of hemoglobin concentration: assessment with in vitro MR spectroscopy. Radiology 1998, 168:489-491.
30. 1. J Magn Reson Imaging 1991, 1:275-283.
31. 31 Meyer M-E, Olivier Y, Eclancher B, et al.: NMR relaxation rates and blood oxygenation level. Magn Reson Med 1995, 34:234-241.
32. 2 and oxygen saturation. J Magn Reson Imaging 1998, 8:1236-1239.
33. 2 and oxygen saturation. J Magn Reson Imaging 1998, 8:1236-1 239.
34. 34 Foltz WD, Merchant N, Downer E, et al.: Coronary venous oxymetry using MRI. Magn Reson Med 1999, 42:837-848. This article documents the feasibility of oxygen measurement in vitro.
35. 35 Kerr AB, Pauly JM, Hu BS, et al.: Real-time interactive MRI on a conventional scanner. Magn Reson Med 1997, 38:355-367.
36. 36 Busse RF, Kruger DG, Debbins JP, et al.: A flexible view ordering technique for high-quality real-time 2DFT MR fluoroscopy. Magn Reson Med 1999, 42:69-81.
37. 37 Yang PC, Kerr AB, Liu AC, et al.: New real-time interactive cardiac magnetic resonance imaging system complements echocardiography. J Am Coll Cardiol 1998, 32:2049-2056.
38. 38 Reeder SB, Atalar E, Faranesh AZ, et al.: Multi-echo segmented k-space imaging: an optimized hybrid sequence for ultrafast cardiac imaging. Magn Reson Med 1999, 41:375-385.
39. 39 Weber OM, Eggers H, Speigel MA, et al.: Real-time interactive magnetic resonance imaging with multiple coils for the assessment of left ventricular function. J Magn Reson Imaging 1999, 10:826-832.
40. 40 Lardo AC: Real-time magnetic resonance imaging: diagnostic and interventional applications. Pediatr Cardiol 2000, 21:80-98. This review article has a very nice overview of current status of real-time, intravascular, transesophageal, and interventional MR imaging.
41. 41 van der Weide R, Zuiderveld KJ, Bakker CJ, et al.: Image guidance of endovascular interventions on a clinical MR scanner. IEEE Trans Med Imaging 1998, 17:779-785.
42. 42 Wacker FK, Reither K, Branding G, et al,: Magnetic resonance-guided vascular catheterization: feasibility using a passive tracking technique at 0.2 Telsa in a pig model. J Magn Reson Imaging 1999, 10:841 -844.
43. 43 Bakker CJG, van der Weide R, Smits HFM: Facilities for monitoring blood flow during MR-guided diagnostic and therapeutic interventions. J Magn Reson Imaging 1999, 10:845-850.
44. 44 Therrien J, Thorne SA, Wright A, et al.: Repaired coarctation: a "cost-effective" approach to identify complications in adults. J Am Coll Cardiol 2000, 35:997-1002. This article emphasizes the usefulness of MR in follow-up evaluation of the coarctation of aorta, based on a large population of patients.
45. 45 Westra SJ, Hill JA, Alejos JC, et al.: Three-dimensional helical CT of pulmonary arteries in infants and children with congenital heart disease. Am J Roentgenol 1999, 173:109-115. This is one of the rare articles describing imaging of pulmonary arteries by three-dimensional CT angiography.
46. 46 Mochizuki T, Murase K. Higashino H, et al.: Two-and three-dimensional CT ventriculography: a new application of helical CT. Am J Roentgenol 2000, 174:203-208. This article describes ventricular functional analysis by using helical or spiral CT scan. Although its real clinical value is questionable, this is definitely a new approach.
47. 47 Kawano T, Ishii M, Takagi J, et al.: Three-dimensional helical computed tomographic angiography in neonates and infants with complex congenital heart disease. Am Heart J 2000, 139:654-660.
48. 48 Ischemic heart disease: clinical features and noninvasive diagnosis. In Imaging of Cardiac Disorders. Edited by Soto B, Kassner EG, Baxley WA. Philadelphia, PA: J.B. Lippincott & Co.; 1992:122-140.
49. 49 Vick III GW, Rokey R, Johnston DL: Nuclear magnetic resonance and positron emission tomography-clinical aspects. In The Science and Practice of Pediatric Cardiology. Edited by Garson A Jr, Bricker JT, McNamara DG. Philadelphia, PA: Lea & Febiger; 1990:852-879.
50. 50 Perloff JK, Henze E, Schelbert HR: Alterations in regional myocardial metabolism, perfusion, and wall motion in Duchenne muscular dystrophy studied by radionuclide imaging. Circulation 1984, 69:33-42.
51. 51 Perloff JK, Roberts WC, de Leon AC Jr, et al.: The distinctive electrocardiogram of Duchenne's progressive muscular dystrophy: an electrocardiographic-pathologic correlative study. Am J Med 1967, 42:179-188.
52. 52 Yoshibayashi M, Tamaki N, Nishioka K, et al.: Regional myocardial perfusion and metabolism assessed by positron emission tomography in children with Kawasaki disease and significance of abnormal Q waves and their disappearance. Am J Cardiol 1991, 68:1638-1645.
53. 53 Rickers C, Lubeck M, Stem H, et al. : Simultaneous assessment of myocardial glucose metabolism and contractile function by gated F-18-deoxyglucose positron emission tomography in infants after arterial switch operation for D-transposition of the great arteries. Prog Pediatr Cardiol 1998, 9:101-107.
54. 54 Donnelly JP, Raffel DM, Shulkin BL, et al.: Resting coronary flow and coronary flow reserve in human infants after repair or palliation of congenital heart defects as measured by positron emission tomography. J Thorac Cardiovasc Surg 1998, 115:103-110.
55. 55 Huffman JI: A critical view of coronary reserve. Circulation 1987, 75:6-11.
56. 56 Qing F, Rahman SU, Hayes MJ, et al.: Effect of long-term beta2-agonist dosing on human cardiac beta-adrenoceptor expression in vivo: comparison with changes in lung and mononuclear leukocyte beta-receptors. J Nucl Cardiol 1997, 4:532-538.
57. 57 Syrota A, Paillotin G, Davy JM, et al.: Kinetics of in vivo binding of antagonist to muscarinic cholinergic receptor in the human heart studied by positron emission tomography. Life Sci 1984, 35:937-945.
58. 58 Coleman RE, Tesar RD: A perspective on clinical PET imaging. Clin Positron Imaging 1999, 2:297-299. This is a comprehensive review of the clinical applications of PET imaging.
59. 59 Miyatake K, Okamoto M, Kinoshita N, et al.: Clinical applications of a new type of real-time two-dimensional Doppler flow imaging system. Am J Cardiol 1984, 54:857-868.
60. 60 McDicken WN, Sutherland GR, Moran CM, et al.: Colour Doppler velocity imaging of the myocardium. Ultrasound Med Biol 1992, 18:651-654.
61. 61 Miyatake K, Yamagishi M, Tanaka N, et al.: New method for evaluating left ventricular Wall motion by color-coded tissue Doppler imaging: in vitro and in vivo studies. J Am Coll Cardiol 1995, 25:717-724.
62. 62 Gorcsan J III, Strum DP, Mandarino WA, et al.: Quantitative assessment of alterations in regional left ventricular contractility with color-coded tissue Doppler echocardiography: comparison with sonomicromety and pressure-volume relations. Circulation 1997, 95:2423-2433.
63. 63 Derumeaux G, Ovize M, Loufoua J, et al.: Assessment of nonuniformity of transmural myocardial velocities by color-coded tissue Doppler imaging: characterization of normal, ischemiec and stunned myocardium. Circulation 2000, 101:1390-1395.
64. 64 Gorcsan J III, Gulati VK, Mandarino WA, et al.: Color-coded measures of myocardial velocity throughout the cardiac cycle by tissue Doppler imaging to quantify regional left ventricular function. Am Heart J 1996, 131:1203-1213.
65. 65 Rodriguez L, Garcia M, Ares M, et al.: Assessment of mitral annular dynamics during diastole by Doppler tissue imaging: comparison with mitral Doppler inflow in subjects without heart disease and in patients with left ventricular hypertrophy. Am Heart J 1996, 131:982-987.
66. 66 Mankad S, Murali S, Kormos RL, et al.: Evaluation of the potential role of color-coded tissue Doppler echocardiography in the detection of allograft rejection in heart transplant recipients. Am Heart J 1999, 138:721 -730.
67. 67 Sutherland GR: Colour Doppler myocardial imaging: potential applications in acquired and congenital heart disease. Acta Paedialr 1995, 410 (suppl):40-48.
68. 68 Mathias W, Arruda A, Santos FC, et al.: Safety of dobutamine-atropine stress echocardiography: a prospective experience of 4033 consecutive studies. J Am Soc Echocardiogr 1999, 12:785-791. This article addresses the safety of DSE.
69. 69 Mertes H, Sawada SG, Ryan T, et al.: Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography: experience in 1118 patients. Circulation 1993, 88:15-19.
70. 70 De Wolf D, Suys B, Maurus R, et al.: Dobutamine stress echocardiography in the evaluation of late anthracycline cardiotoxicity in childhood cancer survivors. Pediatr Res 1996, 39:504-512.
71. 71 Pahl E, Chrystof D, Webb CL, et al.: The feasibility of high-dose dobutamine stress echocardiography in children. Cardiol Young 1997, 7:56-62. One of the initial articles addressing DSE in children
72. 72 Larsen RL, Applegate PM, Dyar DA, et al.: Dobutamine stress echocardiography for assessing coronary artery disease after transplantation. JACC 1998, 32:515-520.
73. 73 Noto N, Ayusawa M, Karasawa K, et al,: Dobutamine stress echocardiography for detection of coronary artery stenosis in children with Kawasaki disease. JACC 1996, 27:1251-1256.
74. 74 Pahl E, Crawford SE, Swenson JM, et al.: Dobutamine stress echocardiography: experience in pediatric heart transplant recipients. J Heart Lung Transplant 1999, 18:725-732. This article presents an important application of DSE.
75. 75 Kimball TR, Witt SA, Daniels SR: Dobutamine stress echocardiography in the assessment of suspected myocardial ischemia in children and young adults. Am J Cardiol 1997, 79:380-383.
76. 76 Leal SM, Carvalho AC, Mathias W, et al.: Dobutamine stress echocardiography in anomalous left coronary artery. Pediatr Cardiol 1998, 19:178-181.
77. 77 Harada K, Tamura M, Ito T, et al.: Effects of low-dose dobutamine on left ventricular diastolic filling in children. Pediatr Cardiol 1996. 17:220-225.
78. 78 Klewer SE, Goldberg SJ, Donnerstein RL, et al.: Dobutamine stress echocardiography: a sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors or childhood cancer, JACC 1992, 19:394-401.
79. 79 DeWolf D, Suys B, Vemaaren H, et al.: Low-dose dobutamine stress echocar-diography in children and young adults. Am J Cardiol 1998, 81:895-901.
80. 80 Kono T, Nishina T, Morita H, et al.: Usefulness of low-dose dobutamine stress echocardiography for evaluating reversibility of brain death-induced myocardial dysfunction. Am J Cardiol 1999, 84:578-582.
81. 81 Bezold LI, Lewin MB, Vick GW, Pignatelli R. Update on new technologies in pediatric echocardiography. Texas Heart Institute Journal 1997, 24:278-286.
82. 82 Kimball TR, Witt SA. The clinical application of pediatric pharmacologic stress echocardiography in evaluating non-ischemic heart disease [abstract]. J Am Soc Echocardiogr 1997; 10:398-401.
83. 83 Shiller N, Shah P, Crawford M, et al.: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2:358-367.
84. 84 Spes CH, Klauss V, Mudra H, et al.: Diagnostic and prognostic value of serial dobutamine stress echocardiography for noinvasive assessment of cardiac allograft vasculopathy. Circulation 1999, 100:509-515.